Skip to content
★ Sign in to follow
OP

ONO Pharmaceutical Co., Ltd. Stock: price and insider trades · Japan

小野薬品工業株式会社

JP·Mcap JP¥1.2THealth Care

ONO Pharmaceutical Co., Ltd.: what insiders have been doing

ONO Pharmaceutical Co., Ltd., classified in the Health Care sector, is a listed company based in Chūō-ku, Japan, founded in 1947. Its insiders report their share dealings to EDINET (Japan FSA). Over the twelve months to 26 October 2026, 3 filings were filed, from 1 insider.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

With 3 filings in twelve months, the company is in line with the median of 3 filings across the 3,205 companies we follow on the same exchange.

Insider buying of ONO Pharmaceutical Co., Ltd. has been absent for the past year. Filings reach the EDINET (Japan FSA) feed a median of 5 days after the trade. The shorter that gap, the sooner other investors can see what insiders have done.

This summary is built from EDINET (Japan FSA) disclosures alone and does not predict where the share price will go.

Insider Decl.
14
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a

Analyst consensus: bullish or bearish?

Analysts rate ONO Pharmaceutical Co., Ltd. Hold (neutral), based on 12 analysts. Average price target: JP¥2,521.

Fundamental score
Ranked 3,794 of 26,911 companies
70.9
score / 100
Value
69
Quality
73
FCF yld7.6%
Earn yld6.3%
EV/EBITDA9.2x
ROE8.9%
Gross mgn73%
Net mgn14%
Debt/EBITDA0.9x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2026

FY ended March 2026 · cache

JP¥2,499
Analyst consensus
12 analysts
Hold
JP¥1,900Target JP¥2,521(+1%)JP¥3,200
Income statement
RevenueJP¥515.8B
Gross profitJP¥374.1B73% margin
EBITDAJP¥133.9B26% margin
Net incomeJP¥69.8B15.1% margin
Valuation
PER (trailing)15.5x
P/Book1.4x
Beta0.14
Balance sheet & cash
Market capJP¥1.2T
Total debtJP¥120.9B
Free Cash FlowJP¥83.6B
Debt / Equity13%
Profitability & ownership
ROE9.3%
ROA6.0%
% insiders12.0%
% institutions40.5%
Last declaration on 5 August 2026
Declarations14 total

14 of 14 declarations

About ONO Pharmaceutical Co., Ltd.

Ono Pharmaceutical Co., Ltd. is a Japanese company specializing in the healthcare and pharmaceutical sector. It focuses on the research, development, and marketing of innovative drugs.